Expert Review of Neurotherapeutics

Papers
(The TQCC of Expert Review of Neurotherapeutics is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
An overview of the differences in the pharmacological management of post-traumatic stress disorder between women and men44
Does electrical stimulation still have a place in the treatment armamentarium for Bell’s palsy?40
The influence of anxiety and depression on headache in adolescent migraineurs: a case-control study40
Where Art Thou O treatment for diabetic neuropathy: the sequel38
Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington’s disease33
Laser interstitial thermal therapy for recurrent brain metastases following stereotactic radiosurgery: a systematic review32
The relevance of cortical thickness in migraine sufferers and implications to therapy30
How have the recent updated epilepsy classifications impacted on diagnosis and treatment?27
Advances in the treatment and management of frontotemporal dementia26
New and emerging pharmacotherapeutic options for the treatment of lennox-gastaut syndrome: moving forward in 202526
Immunomodulatory effects and clinical benefits of intravenous immunoglobulin in myasthenia gravis25
The latest developments with internet-based psychological treatments for depression23
Steps to manage treatment-refractory migraine in adults23
The role of Fecal Microbiota Transplantation (FMT) in treating patients with multiple sclerosis23
The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectives23
Managing antipsychotic-related sexual dysfunction in patients with schizophrenia22
Neuroprotective strategies in multiple sclerosis: a status update and emerging paradigms22
Viloxazine extended-release capsules as an emerging treatment for attention-deficit/hyperactivity disorder in children and adolescents22
Neonatal seizures treatment based on conventional multichannel EEG monitoring: an overview of therapeutic options22
Acute and long-term cognitive impairment following sepsis: mechanism and prevention21
Uncertainties in anti-amyloid monoclonal antibody therapy for Alzheimer’s disease: the challenges ahead21
Why is ADHD so difficult to diagnose in older adults?21
Hesitancies in primary headaches treatments20
An overview of ganaxolone as a treatment for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder20
Correction19
Clinical Insights and Strategies to Managing Depression Subtypes Associated with Tobacco dependence: A Response to the Letter to the Editor19
Spinal automaticity of movement control and its role in recovering function after spinal injury19
Treating subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: an update of the literature18
Epilepsy surgery for seizure control in individuals with Dravet syndrome: is it a safe and practical option?18
Advances in the early diagnosis of amyotrophic lateral sclerosis18
Emerging role for radiomics in the management of intracranial arteriovenous and cavernous malformations18
Electroconvulsive therapy in patients with trauma and personality disorders: what is the evidence?18
Diagnosing epileptic seizures in patients with Alzheimer’s disease and deciding on the appropriate treatment plan18
Mindfulness as a therapeutic option for obsessive-compulsive disorder17
Current use of neurotoxins for alleviating symptoms of cervical dystonia17
An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms17
Virtual reality technology in the treatment of anxiety – progress and future challenges17
Current and emerging diagnostic and management approaches for idiopathic intracranial hypertension17
Multimodal approaches to the treatment of personality disorder16
Advances in gene therapy for high-grade glioma: a review of the clinical evidence16
Distinguishing essential tremor from Parkinson’s disease: clinical and experimental tools16
Efficacy and safety of vigabatrin in patients with tuberous sclerosis complex and infantile epileptic spasm syndrome: a systematic review16
Considerations for hormonal therapy in migraine patients: a critical review of current practice15
Current perspectives on the diagnosis, assessment, and management of vasculitic neuropathy15
The impact of sleep apnea on epilepsy treatment outcomes15
Comparison of the retention rate, safety, and efficacy of two different titration protocols for lamotrigine in newly diagnosed epilepsy patients15
A novel treatment option for intrajejunal levodopa administration14
The differential diagnosis of autism spectrum disorder in adults14
Essential Tremor – Deep Brain Stimulation vs. Focused Ultrasound14
Diagnostic advances and challenges in meningioma14
Illuminating the way: the role of bright light therapy in the treatment of depression14
Persistent post-concussion syndrome: pathophysiology, diagnosis, current and evolving treatment strategies13
Considering hearing loss as a modifiable risk factor for dementia13
Long-term outcomes in refractory status epilepticus13
Trends in disease-modifying therapy use in patients with multiple sclerosis using a 10-year population-based cohort study in France13
Advancements in neuroactive peptides in seizures13
Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective13
Cross-national reflections on medicinal cannabis and depression12
Psychotherapeutic treatments for generalized anxiety disorder: cognitive and behavioral therapies, enhancement strategies, and emerging efforts12
Managing impulse control and related behavioral disorders in Parkinson’s disease: where we are in 2025?12
Updated review of rescue treatments for seizure clusters and prolonged seizures12
Revisiting stimulant use for emotional dysregulation in attention-deficit/hyperactivity disorder (ADHD)12
Frontotemporal dementia. How to deal with its diagnostic complexity?12
Developments in the prediction of cognitive changes following deep brain stimulation in persons with Parkinson’s disease12
The effectiveness of electroconvulsive therapy (ECT) for people with bipolar disorder: is there a specific role?12
Developing personalized treatment strategies for Parkinson’s disease based on disease subtypes12
Using oral topiramate for primary generalized and focal-to-bilateral tonic-clonic seizures in patients 2 years of age and older: a review of the literature12
Advances in the diagnosis of pediatric arterial ischemic stroke – imaging and beyond12
Current perspectives on the recognition and diagnosis of low CSF pressure headache syndromes11
Radiosurgical thalamotomy for essential tremor: state of the art, current challenges and future directions11
Profiling aducanumab as a treatment option for Alzheimer’s disease: an overview of efficacy, safety and tolerability11
Could self-reporting sleep duration become an important tool in the prediction of dementia?11
Therapeutic issues in Guillain–Barré syndrome11
Pathogenesis of comorbid epilepsy in Alzheimer’s disease and use of perampanel, an AMPA receptor inhibitor11
Teriflunomide: an oral therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis11
Imaging protocols for non-traumatic spinal cord injury: current state of the art and future directions11
Family accommodation: a diagnostic feature of obsessive-compulsive disorder?10
Developments in targeting calcitonin gene-related peptide10
Meniere disease subtyping: the direction of diagnosis and treatment in the future10
An update on the role of magnetic resonance imaging in predicting and monitoring multiple sclerosis progression10
Why lithium should be used in patients with bipolar disorder? A scoping review and an expert opinion paper10
Bipolar disorder staging and the impact it has on its management: an update10
Novel approaches for the treatment of frontotemporal dementia: is there hope for the future?10
Medication-overuse headache: can anti-CGRP monoclonal antibodies replace withdrawal?10
Efficacy analysis of three brain stimulation techniques for Alzheimer’s disease: a meta-analysis of repeated transcranial magnetic stimulation, transcranial direct current stimulation, and deep brain 10
Imaging of infectious and inflammatory cystic lesions of the brain, a narrative review10
Combinations of dextromethorphan for the treatment of mood disorders - a review of the evidence10
Long-term central nervous system (CNS) consequences of COVID-19 in children9
Rethinking the role of trazodone in the different depressive dimensions9
Omaveloxolone for the treatment of Friedreich ataxia: clinical trial results and practical considerations9
Important context missing from “contemporary perspectives in cerebral amyloid angiopathy”9
What is the potential of paramagnetic rim lesions as diagnostic indicators in multiple sclerosis?9
The pivotal role of central sensitization in long COVID, fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome9
Stem cell therapy for patients with paraplegia: is there hope for the future?9
Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions9
Pharmacological and non-pharmacological treatment options for sleep disturbances in Alzheimer’s disease9
Contemporary perspectives in cerebral amyloid angiopathy9
Neuromodulation as a treatment strategy in Lennox-Gastaut syndrome: evidence and future directions9
Cognitive or daily stress association with headache and pain induction in migraine and tension-type headache patients: a systematic review9
Risk of suicide and suicide-related events in subjects treated with antiseizure medications8
Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s disease8
The benefits and risks of escalation versus early highly effective treatment in patients with multiple sclerosis8
Contemporary diagnosis and treatment of conduct disorder in youth8
Suicide and suicidal behaviors: insight into clinical challenges and preventive measures8
What are the main challenges in the treatment of neonatal hypoxic ischemic encephalopathy?8
Tobacco use disorder and depression: emerging strategies and recommendations:8
Combination of noninvasive brain stimulation and constraint-induced movement therapy in patients with stroke: a systematic review and meta-analysis8
The challenges and opportunities related to the therapeutic use of music in psychiatry8
Learnings in developmental and epileptic encephalopathies: what do we know?8
Ublituximab-xiiy as a treatment option for relapsing multiple sclerosis8
Re-evaluating the prognosis of schizophrenia: tackling the issue of inadequate treatment8
The major challenges with pharmacologic management of chronic traumatic encephalopathy8
Deep brain stimulation: new programming algorithms and teleprogramming8
0.079249858856201